U.S., June 14 -- ClinicalTrials.gov registry received information related to the study (NCT07021313) titled 'Deliver mOre aPplications for More Durable Pulmonary Vein IsOlation' on May 30.
Brief Summary: Pulmonary vein isolation (PVI) by catheter ablation (CA) has become a widely accepted interventional treatment for patients with symptomatic atrial fibrillation (AF) despite anti-arrhythmic drugs (AAD). Classic thermal ablation modalities use radiofrequency energy or cryo-energy to create cardiac tissue lesions. Irreversible electroporation (IRE) using pulsed field energy (PFA) is a novel technology for cardiac tissue ablation. Initial studies have shown favorable outcome data in patients with AF treated by performing PVI using PFA. Howeve...